| scholarly article | Q13442814 |
| P2093 | author name string | Lee CH | |
| Lee J | |||
| Lee SK | |||
| Park YB | |||
| Lee WK | |||
| Lee CW | |||
| Song CH | |||
| Suh CH | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1701-1704 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Lipid profiles in untreated patients with rheumatoid arthritis | |
| P478 | volume | 26 |
| Q36469043 | A Systematic Literature Review of the Association of Lipoprotein(a) and Autoimmune Diseases and Atherosclerosis |
| Q52691095 | Abnormal lipid metabolism in a rat model of arthritis: one possible pathway. |
| Q34348277 | Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study. |
| Q48444714 | Anti-arthritogenic and cardioprotective action of hesperidin and daidzein in collagen-induced rheumatoid arthritis |
| Q33355906 | Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis |
| Q24798517 | Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production? |
| Q35552716 | Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis |
| Q41670041 | Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis. |
| Q36238859 | Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals |
| Q34897630 | Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study |
| Q36596894 | Atherogenic lipid profiles and its management in patients with rheumatoid arthritis |
| Q35553376 | Atherosclerotic cardiovascular disease in rheumatoid arthritis |
| Q41479441 | Autoimmune Lymphoproliferative Syndrome: A Rare Cause of Disappearing HDL Syndrome. |
| Q63683454 | Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q36835851 | Cardiovascular co-morbidity in rheumatic diseases |
| Q38115132 | Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm |
| Q35954510 | Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis |
| Q35645759 | Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis |
| Q33430317 | Comparative analysis of synovial fluid and plasma proteomes in juvenile arthritis--proteomic patterns of joint inflammation in early stage disease. |
| Q36830958 | Correlation of Paraoxonase Status with Disease Activity Score and Systemic Inflammation in Rheumatoid Arthritic Patients |
| Q35029916 | Dyslipidaemia in rheumatological autoimmune diseases |
| Q36113215 | Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy |
| Q35552265 | Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study |
| Q33910884 | Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency |
| Q83299924 | Ethnicity may be a reason for lipid changes and high Lp(a) levels in rheumatoid arthritis |
| Q44205248 | Evaluation of the cholesterol influence in type II collagen-induced arthritis in DBA/1J mice: an autoradiographic study. |
| Q46090128 | High frequency of lipoprotein risk levels for cardiovascular disease in Takayasu arteritis |
| Q36155818 | High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study |
| Q36245981 | High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study |
| Q43091605 | High-density lipoprotein: does it have a dark side? |
| Q37612713 | IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis |
| Q34614038 | Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study |
| Q38287565 | Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship? |
| Q45220629 | Influence of serum folic acid levels on plasma homocysteine concentrations in patients with rheumatoid arthritis |
| Q51652663 | Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial |
| Q37723594 | Lipid abnormalities in patients with Rheumatoid Arthritis |
| Q38026796 | Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies |
| Q39054846 | Lipid profile in Tunisian patients with rheumatoid arthritis |
| Q35638659 | Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis |
| Q45256816 | Lipoprotein profile in limited systemic sclerosis. |
| Q34037325 | Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis |
| Q47959078 | Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis. |
| Q45004490 | Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation |
| Q37058791 | Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion |
| Q53584799 | Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. |
| Q54985574 | Metabolic fingerprinting of joint tissue of collagen-induced arthritis (CIA) rat: In vitro, high resolution NMR (nuclear magnetic resonance) spectroscopy based analysis. |
| Q37350896 | Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study |
| Q35673987 | Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis |
| Q51545006 | Modulation of autoimmune arthritis severity in mice by apolipoprotein E (ApoE) and cholesterol. |
| Q36204149 | Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis |
| Q30389180 | Monascus purpureus-fermented Thai glutinous rice reduces blood and hepatic cholesterol and hepatic steatosis concentrations in diet-induced hypercholesterolemic rats |
| Q35521069 | New insights into the mechanism of low high-density lipoprotein cholesterol in obesity |
| Q35638493 | Patterns of cardiovascular risk in rheumatoid arthritis |
| Q43450932 | Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population |
| Q35746865 | Plasma apolipoprotein(a) co-deposits with fibrin in inflammatory arthritic joints |
| Q41915915 | Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine |
| Q36721867 | Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production |
| Q35309510 | Protective molecules and their cognate antibodies: new players in autoimmunity |
| Q35869041 | Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis |
| Q45669904 | Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis |
| Q37140079 | Rheumatoid arthritis and cardiovascular disease |
| Q36812587 | Rheumatoid arthritis and cardiovascular disease: an update on treatment issues |
| Q36388793 | Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity. |
| Q50318500 | Serum Lipid Alterations in Early Rheumatoid Arthritis Patients on Disease Modifying Anti Rheumatoid Therapy |
| Q38518891 | Serum oxidized low-density lipoproteins in rheumatoid arthritis |
| Q37033345 | Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention |
| Q50192090 | The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis |
| Q24812699 | The contact-mediated response of peripheral-blood monocytes to preactivated T cells is suppressed by serum factors in rheumatoid arthritis |
| Q38671481 | The dynamic evolution of rheumatology in Korea |
| Q37343272 | The impact of inflammation on metabolomic profiles in patients with arthritis |
| Q35092457 | The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. |
| Q34731185 | The role of human T-lymphocyte-monocyte contact in inflammation and tissue destruction |
| Q33931317 | Total cholesterol and LDL levels decrease before rheumatoid arthritis |
| Q37479238 | Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study |
| Q81772565 | [T cell-dependent monocyte activation, TNFalpha and apolipoprotein A-I in autoimmunity and inflammation] |
Search more.